Skip to Main Content

Paper Details

Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.
Clin Cancer Res
0
2023
-, -PDGFRA) fusion, Avapritinib, FIP1-like 1 protein, FIP1L1, LEAP, Leukemia, Lymphoblastic Lymphoma, PDGFRA, PDGFRA p.D842N leukemia, Patients, T, T-ALL, T-ALL PDX model, T-Cell Acute Lymphoblastic Leukemia, T-LBL, T-cell acute lymphoblastic leukemia, avapritinib, leukemia, lymphoblastic lymphoma, mice, mouse, mouse patient-derived xenograft, patient, patients, pediatric, platelet-derived growth factor receptor-
Author NameAffiliation
Benjamin L EbertDana-Farber Cancer Institute
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenDana-Farber Cancer Institute
Sarah K TasianDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, and Department of Pediatrics and Abramson Cancer Center at the Perelman School of Medicine at the University of Pennsylvania
Charles G MullighanSt. Jude Children's Research Hospital
Marlise R LuskinDana-Farber Cancer Institute
Brenton G Mar
Matthew P JacobsonDepartment of Pharmaceutical Chemistry, University of California San Francisco
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBroad Institute of Massachusetts Institute of Technology and Harvard University
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierBroad Institute of Massachusetts Institute of Technology and Harvard University
Yana PikmanDana-Farber Cancer Institute
Yana PikmanBoston Children's Hospital
  • 1 - 16

Datasets

Release 1.2